Olympiad Research’s HCA Healthcare HCA Stock Holding History

Olympiad Research’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,830	Closed	-$275K	–	393
2020 Q2	$275K	Buy	+2,830	New	+$294K	0.2%	135

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Olympiad Research's HCA Position: Q3 2020 in Review

Olympiad Research sold out of HCA Healthcare (HCA) in Q3 2020, closing a stake of 2,830 shares — an estimated $275K sold.

Olympiad Research first reported a position in HCA in Q2 2020 and held it in 1 quarter. The position peaked at $275K in Q2 2020. 719 funds tracked by Wall St. Rank hold HCA as of Q3 2020.

Olympiad Research reported no remaining HCA Healthcare position as of Q3 2020 after selling out during the quarter.
Olympiad Research sold 2,830 HCA Healthcare shares in Q3 2020, an estimated $275K.
Olympiad Research first reported a position in HCA Healthcare in Q2 2020 and held it in 1 quarter.
Olympiad Research's HCA Healthcare position peaked at $275K in Q2 2020.
719 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2020.

Based on Olympiad Research's 13F filing for Q3 2020, filed 2 Nov 2020.